Monday, 2 March 2020

Latest Papers from the Musculoskeletal Research Group

PubMed Results

1. Serum CXCL13 levels are associated with lymphoma risk and lymphoma occurrence in primary Sjögren's syndrome.
Traianos EY, Locke J, Lendrem D, Bowman S, Hargreaves B, Macrae V; UK primary Sjögren's syndrome registry, Tarn JR, Ng WF.
Rheumatol Int. 2020 Feb 11. doi: 10.1007/s00296-020-04524-5. [Epub ahead of print]
PMID: 32047959 [PubMed - as supplied by publisher]
Similar articles
2. Arthritis prevention in the pre-clinical phase of RA with abatacept (the APIPPRA study): a multi-centre, randomised, double-blind, parallel-group, placebo-controlled clinical trial protocol.
Al-Laith M, Jasenecova M, Abraham S, Bosworth A, Bruce IN, Buckley CD, Ciurtin C, D'Agostino MA, Emery P, Gaston H, Isaacs JD, Filer A, Fisher BA, Huizinga TWJ, Ho P, Jacklin C, Lempp H, McInnes IB, Pratt AG, Östor A, Raza K, Taylor PC, van Schaardenburg D, Shivapatham D, Wright AJ, Vasconcelos JC, Kelly J, Murphy C, Prevost AT, Cope AP.
Trials. 2019 Jul 15;20(1):429. doi: 10.1186/s13063-019-3403-7.
PMID: 31307535 [PubMed - indexed for MEDLINE] Free PMC Article
Similar articles
3. Routine musculoskeletal ultrasound findings impact diagnostic decisions maximally in autoantibody-seronegative early arthritis patients.
Iqbal K, Lendrem DW, Hargreaves B, Isaacs JD, Thompson B, Pratt AG.
Rheumatology (Oxford). 2019 Jul 1;58(7):1268-1273. doi: 10.1093/rheumatology/kez008.
PMID: 30753709 [PubMed - indexed for MEDLINE]
Similar articles
4. Expression of STAT3-regulated genes in circulating CD4+ T cells discriminates rheumatoid arthritis independently of clinical parameters in early arthritis.
Anderson AE, Maney NJ, Nair N, Lendrem DW, Skelton AJ, Diboll J, Brown PM, Smith GR, Carmody RJ, Barton A, Isaacs JD, Pratt AG.
Rheumatology (Oxford). 2019 Jul 1;58(7):1250-1258. doi: 10.1093/rheumatology/kez003.
PMID: 30753680 [PubMed - indexed for MEDLINE] Free PMC Article
Similar articles

Thursday, 20 February 2020

Tilly Hale Award - Deadline is 20th March

More on the Tilly Hale Award to support public engagement and patient involvement in your research. 

Please see the following link:


INsTRuCT website is live!

Check out this exciting new network - INsTRuCT is an EU-funded Innnovative Training Network, aiming to train the next generation of researchers in the cellular therapy field. 



Tuesday, 3 December 2019

MRG November Publications

Featuring Tolergenic dendritic cells, MRI and rituximab for JIA patients.

Targeting of tolerogenic dendritic cells to heat-shock proteins in inflammatory arthritis.
Spiering R, Jansen MAA, Wood MJ, Fath AA, Eltherington O, Anderson AE, Pratt AG, van Eden W, Isaacs JD, Broere F, Hilkens CMU.
J Transl Med. 2019 Nov 14;17(1):375. doi: 10.1186/s12967-019-2128-4.
PMID: 31727095 [PubMed - in process] Free Article
Similar articles 

Can quantitative MRI be used in the clinical setting to quantify the impact of intra-articular glucocorticoid injection on synovial disease activity in juvenile idiopathic arthritis?
Bennett JL, Wood A, Smith N, Mistry R, Allen K, Jandial S, Tuckett JD, Gowdy SC, Foster HE, McErlane F, Hollingsworth KG.
Pediatr Rheumatol Online J. 2019 Nov 21;17(1):74. doi: 10.1186/s12969-019-0377-7.
PMID: 31752877 [PubMed - in process] Free PMC Article
Similar articles 

Use and effectiveness of rituximab in children and young people with juvenile idiopathic arthritis in a cohort study in the United Kingdom.
Kearsley-Fleet L, Sampath S, McCann LJ, Baildam E, Beresford MW, Davies R, De Cock D, Foster HE, Southwood TR, Thomson W, Hyrich KL.
Rheumatology (Oxford). 2019 Feb 1;58(2):331-335. doi: 10.1093/rheumatology/key306.
PMID: 30358861 [PubMed - indexed for MEDLINE] Free PMC Article
Similar articles